<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
>

<channel>
	<title>Pharma Exec Blog &#187; Cozaar</title>
	<atom:link href="http://blog.pharmexec.com/tag/cozaar/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Wed, 08 Feb 2012 16:14:43 +0000</lastBuildDate>
	
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<!-- podcast_generator="podPress/8.8" -->
		<copyright>&#xA9;Advanstar Communications </copyright>
		<managingEditor>gkoroneos@advanstar.com (Advanstar Communications)</managingEditor>
		<webMaster>gkoroneos@advanstar.com(Advanstar Communications)</webMaster>
		<category>Pharmceuticals</category>
		<ttl>1440</ttl>
		<itunes:keywords>pharma, pharmaceuticals, life science, business, news, pharmexec, unplugged</itunes:keywords>
		<itunes:subtitle></itunes:subtitle>
		<itunes:summary>The Business of Pharmaceuticals</itunes:summary>
		<itunes:author>Advanstar Communications</itunes:author>
		<itunes:category text="Science &amp; Medicine">
  <itunes:category text="Medicine"/>
</itunes:category>
<itunes:category text="Science &amp; Medicine">
  <itunes:category text="Medicine"/>
</itunes:category>
<itunes:category text="Business">
  <itunes:category text="Management &amp; Marketing"/>
</itunes:category>
		<itunes:owner>
			<itunes:name>Advanstar Communications</itunes:name>
			<itunes:email>gkoroneos@advanstar.com</itunes:email>
		</itunes:owner>
		<itunes:block>No</itunes:block>
		<itunes:explicit>no</itunes:explicit>
		<itunes:image href="http://lifeinabungalo.com/art/pharmaunplugged_300x30.jpg" />
		<image>
			<url>http://lifeinabungalo.com/art/pharmaunplugged_300x30.jpg</url>
			<title>Pharma Exec Blog</title>
			<link>http://blog.pharmexec.com</link>
			<width>144</width>
			<height>144</height>
		</image>
		<item>
		<title>Merck&#039;s Yarno Waves Goodbye</title>
		<link>http://blog.pharmexec.com/2008/07/14/mercks-yarno-waves-goodbye/</link>
		<comments>http://blog.pharmexec.com/2008/07/14/mercks-yarno-waves-goodbye/#comments</comments>
		<pubDate>Mon, 14 Jul 2008 19:07:21 +0000</pubDate>
		<dc:creator>Joanna Breitstein</dc:creator>
				<category><![CDATA[People]]></category>
		<category><![CDATA[CMO]]></category>
		<category><![CDATA[Cozaar]]></category>
		<category><![CDATA[Hyzaar]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Wendy Yarno]]></category>

		<guid isPermaLink="false">http://blog.pharmexec.com/2008/07/14/mercks-yarno-waves-goodbye/</guid>
		<description><![CDATA[After more than 25 years at Merck, Wendy Yarno, the company&#8217;s chief marketing officer, will retire. The announcement of Yarno&#8217;s stepping down was made this morning in an e-mail to Merck employees.
Yarno joined Merck in 1983 as a sales rep, went on to launch Cozaar and Hyzaar, and then eventually was named to oversee marketing [...]]]></description>
			<content:encoded><![CDATA[<p>After more than 25 years at Merck, Wendy Yarno, the company&#8217;s chief marketing officer, will retire. The announcement of Yarno&#8217;s stepping down was made this morning in an e-mail to Merck employees.</p>
<p>Yarno joined Merck in 1983 as a sales rep, went on to launch Cozaar and Hyzaar, and then eventually was named to oversee marketing for Merck&#8217;s human healthcare business. Most recently, she received press for her pivotal role in launching Januvia.</p>
<p>Yarno has been out in front, talking about the importance of Merck&#8217;s transformation and the need to create better alignment among the different functions at the company. But all this alignment suggests that Yarno&#8217;s retirement might have come a bit earlier than expected. A source inside the company reveals that this is just the first of many other changes expected to be announced shortly.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.pharmexec.com/2008/07/14/mercks-yarno-waves-goodbye/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

